BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31284950)

  • 1. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β.
    Shen Y; Chen S; Zhao Y
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1137-1144. PubMed ID: 31284950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfiredoxin-1 protects retinal ganglion cells from high glucose-induced oxidative stress and inflammatory injury by potentiating Nrf2 signaling via the Akt/GSK-3β pathway.
    Zhu F; Shao J; Tian Y; Xu Z
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108221. PubMed ID: 34653733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation.
    Feng J; Xie L; Yu X; Liu C; Dong H; Lu W; Kong R
    Biochem Biophys Res Commun; 2021 Mar; 544():22-30. PubMed ID: 33516878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway.
    Chen Z; Tian L; Wang L; Ma X; Lei F; Chen X; Fu R
    Inflammation; 2022 Jun; 45(3):992-1006. PubMed ID: 34783942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRD4 contributes to high-glucose-induced podocyte injury by modulating Keap1/Nrf2/ARE signaling.
    Zuo H; Wang S; Feng J; Liu X
    Biochimie; 2019 Oct; 165():100-107. PubMed ID: 31325480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing REDD1 expression protects against high glucose-induced apoptosis, oxidative stress and inflammatory injury in podocytes through regulation of the AKT/GSK-3β/Nrf2 pathway.
    Wang X; Yang J; Wang W; Li Y; Yang Y
    Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):527-538. PubMed ID: 36883011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHLPP2 downregulation protects cardiomyocytes against hypoxia-induced injury through reinforcing Nrf2/ARE antioxidant signaling.
    Jin A; Li B; Li W; Xiao D
    Chem Biol Interact; 2019 Dec; 314():108848. PubMed ID: 31610156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of BRD7 protects podocytes against high glucose-induced apoptosis by enhancing Nrf2 in a GSK-3β-dependent manner.
    Yu X; Jiang N; Li J; Li X; He S
    Tissue Cell; 2022 Jun; 76():101813. PubMed ID: 35550209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of lemur tyrosine kinase-2 protects neurons from oxygen-glucose deprivation/reoxygenation-induced injury through reinforcement of Nrf2 signaling by modulating GSK-3β phosphorylation.
    Bao H; Gao M
    Biochem Biophys Res Commun; 2020 Jan; 521(4):964-970. PubMed ID: 31722791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of FGF19 alleviates hypoxia/reoxygenation-induced injury of cardiomyocytes by regulating GSK-3β/Nrf2/ARE signaling.
    Fang Y; Zhao Y; He S; Guo T; Song Q; Guo N; Yuan Z
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2355-2362. PubMed ID: 29964017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDAG51-Deficiency Podocytes are Protected from High-Glucose-Induced Damage Through Nrf2 Activation via the AKT-GSK-3β Pathway.
    Liu C; Li Y; Wang X
    Inflammation; 2022 Aug; 45(4):1520-1533. PubMed ID: 35175494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSKIP protects cardiomyocytes from hypoxia/reoxygenation-induced injury by enhancing Nrf2 activation via GSK-3β inhibition.
    Yan L; Cheng G; Yang G
    Biochem Biophys Res Commun; 2020 Oct; 532(1):68-75. PubMed ID: 32828530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
    Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
    Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of PHLPP1 ameliorates high glucose-evoked injury in retinal ganglion cells by attenuating apoptosis and oxidative stress through enhancement of Nrf2 activation.
    Zhang X; Lu Y; He N; Wang F
    Exp Cell Res; 2020 Dec; 397(2):112344. PubMed ID: 33164862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaredoxin 1 protects neurons from oxygen-glucose deprivation/reoxygenation (OGD/R)-induced apoptosis and oxidative stress via the modulation of GSK-3β/Nrf2 signaling.
    Qiu Z; Li X; Duan C; Li R; Han L
    J Bioenerg Biomembr; 2021 Aug; 53(4):369-379. PubMed ID: 33956252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: Role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3β.
    Song JS; Kim EK; Choi YW; Oh WK; Kim YM
    Toxicol Appl Pharmacol; 2016 Sep; 307():138-149. PubMed ID: 27511913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Glutaredoxin 2 alleviates oxygen-glucose deprivation/reoxygenation-induced apoptosis and ROS production in neurons by enhancing Nrf2 signaling via modulation of GSK-3β.
    Wen J; Li X; Zheng S; Xiao Y
    Brain Res; 2020 Oct; 1745():146946. PubMed ID: 32522629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescence marker protein 30 (SMP30) protects against high glucose-induced apoptosis, oxidative stress and inflammatory response in retinal ganglion cells by enhancing Nrf2 activation via regulation of Akt/GSK-3β pathway.
    Zhang L; Zhu T; He F; Li X
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108238. PubMed ID: 34688152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 2 protects against oxygen-glucose deprivation/reoxygenation-induced neuronal injury by enhancing Nrf2 activation via GSK-3β modulation.
    Bai J; Jia P; Zhang Y; Wang K; Wu G
    Hum Exp Toxicol; 2021 Aug; 40(8):1342-1354. PubMed ID: 33624547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
    Zhang Q; Hu Y; Hu JE; Zhang M
    Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.